GSROX | NRGSX | GSROX / NRGSX | |
Total Expense Ratio | 1.46 | 0.74 | 197% |
Annual Report Gross Expense Ratio | 1.68 | 0.74 | 227% |
Fund Existence | 18 years | 13 years | - |
Gain YTD | 14.681 | -3.902 | -376% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 172M | 8.71B | 2% |
Annual Yield % from dividends | 0.90 | 0.06 | 1,379% |
Returns for 1 year | 14.97 | -10.12 | -148% |
Returns for 3 years | 69.17 | 5.90 | 1,172% |
Returns for 5 years | -53.83 | -2.32 | 2,319% |
Returns for 10 years | -45.44 | 10.24 | -444% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
RYVYX | 700.65 | 8.79 | +1.27% |
Rydex NASDAQ-100® 2x Strategy H | |||
CCERX | 29.96 | 0.17 | +0.57% |
Columbia Large Cap Enhanced Core R | |||
GMVAX | 16.47 | 0.04 | +0.24% |
Goldman Sachs Small/Mid Cap Equity A | |||
FCVIX | 19.93 | 0.03 | +0.15% |
Fidelity Advisor Small Cap Value I | |||
CLBAX | 38.93 | 0.05 | +0.13% |
American Funds American Balanced 529A |